![](https://investorshub.advfn.com/uicon/40536.png?cb=1561902029)
Thursday, March 21, 2019 5:36:12 PM
Going by memory, so forgive some errors!
-Patel and Ichim are irrelevant to the company and just churn out meaningless patents that have no bearing.
-It matters not to CMTH that that Ichim, Gershman and Warbington were associated to Medistem.
-CMH was at one time a Delaware Corp, but is no longer, therefore CMH has dissolved and is no longer a legal entity.
-Since CMTH is linked to CMH, therefore CMTH is not a legal entity.
-The company no longer occupies or uses the Peoria address, but the address lingers on many documents is further proof that the company is illegitimate.
-TW was associated with another company that was involved in a lawsuit, so everything else about him is suspect.
-There is no evidence that any of the patented stem cell treatments work
-CMTH, being an illegitimate company, is nothing more that a share selling scheme that duped several doctors into participating.
-Some of the treating doctors at one time in their career had a complaint filed on them, so anything they do now is suspect, and they may have not been duped into CMTH, they may be complicit in the scheme.
-The trial results registered on the .gov website is a sham, and therefore the results came out poor and CMTH his purposefully hiding the results by not issuing their paper while they dilute as many shares as possible.
-To perpetuate the scheme, one of the scheming doctors has showed a picture of boxes and lied about them being Caverstem kits and there is no evidence that CMTH sells them at all.
-Even though there is no evidence that CMTH has anything of value, and no evidence that they are providing $1600.00 harvest kits, even if they were selling kits, they are just sourcing inexpensive biopsy kits, providing further evidence of the scheme.
-All of this and more is flying under the radar of the regulators and authorities because the OTC just has too many scams to police, but you plan to call the AZ AG and more and get justice.
Recent CELZ News
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/05/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:02:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:45:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • Business Wire • 03/27/2024 01:00:00 PM
- Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access • Business Wire • 03/07/2024 02:15:00 PM
- Biotech Finds Mid-Week Success Following FDA Announcement • AllPennyStocks.com • 03/06/2024 09:10:00 PM
- Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy • Business Wire • 03/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:05:37 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 11/15/2023 01:00:00 PM
- Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain • PR Newswire (US) • 10/10/2023 12:00:00 PM
- Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain • PR Newswire (US) • 09/19/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:45:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/29/2023 09:37:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 01:00:18 PM
- Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing Requirements • PR Newswire (US) • 06/28/2023 12:00:00 PM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM